Ticker Details
Neumora Therapeutics, Inc.
IPO Date:	September 15, 2023
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$576.09M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.26 | 3.77%
Avg Daily Range (30 D):	$0.10 | 4.06%
Avg Daily Range (90 D):	$0.10 | 4.35%

Institutional Daily Volume
Avg Daily Volume:	1.07M
Avg Daily Volume (30 D):	1.6M
Avg Daily Volume (90 D):	1.9M

Trade Size
Avg Trade Size (Sh.):	150
Avg Trade Size (Sh.) (30 D):	204
Avg Trade Size (Sh.) (90 D):	208

Institutional Trades
Total Institutional Trades:	298
Avg Institutional Trade:	$1.86M
Avg Institutional Trade (30 D):	$3.74M
Avg Institutional Trade (90 D):	$3.1M
Avg Institutional Trade Volume:	.24M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.34M
Avg Closing Trade (30 D):	$5.12M
Avg Closing Trade (90 D):	$5.12M
Avg Closing Volume:	292.74K

News

Feb 4, 2026 @ 12:00 PM Neumora Therapeutics to Participate in Gugge... Source: Na

Nov 18, 2025 @ 6:02 PM Top 3 Biotech Stocks Capitalizing on the AI Revolu... Source: Timothy Fries

Oct 1, 2025 @ 11:00 AM Neumora Therapeutics to Host Virtual R&D Day on Oc... Source: Helen Rubinstein

Jul 23, 2025 @ 11:00 AM Neumora Therapeutics to Report Second Quarter 2025... Source: Helen Rubinstein

Jul 9, 2025 @ 11:00 AM Neumora Therapeutics Announces Initiation of Phase... Source: Nick Brandon, Ph.D.

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS		$-.35	$-.33
Diluted EPS		$-.35	$-.33
Revenue		$M	$M
Gross Profit
Net Income / Loss		$-56.76M	$-52.73M
Operating Income / Loss		$-57.7M	$-54.04M
Cost of Revenue
Net Cash Flow		$4.55M	$-18.84M
PE Ratio